Abstract Submission Rules & Regulations
SUBMITTING AN ABSTRACT
Abstract Submission Deadline: Friday, 5 February 2021
- All accepted abstracts will be included in the Annual Meeting online abstract supplement and will be published in the Journal of the Peripheral Nervous System (JPNS) as submitted.
- The character limit for all abstracts is 300 words NOT including Title and Authors.
- Presenting authors of accepted abstracts will be required to register for the meeting (Junior Members presenting abstracts are eligible for gratis registration). Registration opens in March.
- All presenting authors are expected to stand by their poster(s) for the full duration of their designated stand by time.
- Authors have the option to submit their abstract for one of the two following options:
– Poster Presentation only
– Oral and Poster Presentation
- Tables, graphs, and images are not permitted.
- Avoid trade names whenever possible. Sometimes you need to say the trade name at least once, for clarity. For instance – natalizumab (Tysabri).
Preparation of Your Abstract
- No identifying features such as names of hospitals, medical schools, clinics, or cities may be listed in the title or text of the abstract. Do not include the names of any of the authors. The names of authors and their affiliations (institutions) will be submitted on-line during the process.
- Abstracts previously presented at a national/international meeting may be submitted to the PNS. Please cite the meeting, location, and date of previous presentation. Abstracts cannot be previously published.
- The title cannot be longer than (15) words but should clearly indicate the nature of the study. Capitalize the first letter of each word within the title. Avoid abbreviations whenever possible.
- Abstracts should state briefly and clearly the purpose, methods, results, and conclusions of the work. There is a strict 300-word limit (title and references not included).
– Clearly state the purpose of the abstract.
– Describe your selection of observations or experimental subjects.
– Present your results in a logical sequence.
– Emphasize new and important aspects of the study and conclusions that are drawn from them.
PNS ABSTRACT WITHDRAWAL POLICY
It is the PNS’ expectation that all accepted abstracts will, under all usual circumstances, be presented at the meeting. If the presenting author is unable to present an abstract, a co-author is eligible to present on their behalf. Failure to present an accepted abstract may cause the author(s) to be ineligible for abstract submission at next year’s Annual Meeting. To request withdrawal of an abstract, please submit the request in writing to meetings@PNSociety.com.
SELECTION OF ABSTRACTS
The abstract review process is completed by the PNS Scientific Program Committee. As peers, they carefully review each abstract for content/consideration. The Editor-in-Chief of the JPNS is part of this peer review process and reviews the submission for publication.
Accepted abstracts will be published as a compilation in an abstract supplement of our Journal, the Journal of the Peripheral Nervous System (JPNS), under copyright by the Peripheral Nerve Society. Individual abstracts are not copyrighted by the Society, and you are free to publish or present your work elsewhere.
Abstract AWARD CRITERIA
For ALL abstract awards:
- The abstract presenter must be a current Junior Member of PNS at the time the abstract is submitted. Please click here for more information on PNS membership.
- The recipient is required to attend the Annual Meeting.
Arthur K. Asbury Award: The abstract must pertain to GBS/CIDP/Inflammatory.
Richard P. Bunge Award: The abstract must pertain to nerve biology.
Peter J. Dyck Award: The abstract must pertain to diabetes and clinical topics.
J.W. Griffin Award: The abstract must pertain to regeneration.
Pembroke Award: The presenting author must be from Australia or Asia.
P.K. Thomas Award: The abstract must pertain to inherited neuropathies.
Richard A.C. Hughes Award: The abstract must pertain to clinical topics.
In evaluating each presentation, the prize committee will consider the quality of the presentation, groudbreaking/innovative results, and the quality of the presenter.